Gamida Cell is an advanced cell therapy company committed to finding cures for cancer and other serious diseases. We apply a proprietary expansion platform to allogeneic cell sources, including umbilical cord blood-derived cells and NK cells, which leverages the properties of nicotinamide (NAM) to create products with the potential to redefine standards of care.
Omidubicel, Gamida Cell’s lead investigational product candidate, is under development as a potential life-saving allogeneic hematopoietic stem cell (bone marrow) transplant solution for patients with hematologic malignancies, and has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration. Omidubicel met all of its primary and secondary endpoints in a Phase 3 study. Gamida Cell plans to submit a BLA for omidubicel by the end of 2021 with an anticipated product approval and launch in mid-2022. Gamida Cell is also pioneering modified and unmodified NAM-enabled NK cell therapies targeted at solid tumor and hematological malignancies.
Gamida Cell is a global, publicly traded biotechnology company (Nasdaq: GMDA) with locations in Israel and the United States. Additional information can be found on our website at www.gamida-cell.com.
General Scope and Summary
Working with cross-functional teams and external collaborators, the Medical Director will take a leadership role in the creation and execution of clinical development plans, medical oversight and interactions with investigators and other critical clinical stakeholders. This is a hands-on role, both involved with providing strategic insights to advance clinical programs while also being able to develop and execute well-defined plans all while leading within a cross-functional organization where our values in action are prioritized.
Roles and Responsibilities
Experience, Education and Specialized Knowledge and Skills
Travel: Up to 25%, once travel resumes
Reports to: Vice President, Clinical development
To apply: Send resume and cover letter to email@example.com.